(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 17571.60 | 14327.50 | 22.64 | 17571.60 | 14327.50 | 22.64 | 60890.70 | 52169.80 | 16.72 |
| Other Income | 200.70 | 215.20 | -6.74 | 200.70 | 215.20 | -6.74 | 774.30 | 1004.70 | -22.93 |
| PBIDT | 5191.30 | 3489.00 | 48.79 | 5191.30 | 3489.00 | 48.79 | 15156.90 | 10448.00 | 45.07 |
| Interest | 352.00 | 438.90 | -19.80 | 352.00 | 438.90 | -19.80 | 1429.60 | 1822.00 | -21.54 |
| PBDT | 4839.30 | 3050.10 | 58.66 | 4839.30 | 3050.10 | 58.66 | 13727.30 | 8626.00 | 59.14 |
| Depreciation | 957.60 | 935.70 | 2.34 | 957.60 | 935.70 | 2.34 | 3786.40 | 3587.90 | 5.53 |
| PBT | 3881.70 | 2114.40 | 83.58 | 3881.70 | 2114.40 | 83.58 | 9940.90 | 5038.10 | 97.31 |
| TAX | 982.10 | 535.00 | 83.57 | 982.10 | 535.00 | 83.57 | 2536.10 | 1234.20 | 105.49 |
| Deferred Tax | -50.40 | -61.60 | -18.18 | -50.40 | -61.60 | -18.18 | -315.10 | -304.20 | 3.58 |
| PAT | 2899.60 | 1579.40 | 83.59 | 2899.60 | 1579.40 | 83.59 | 7404.80 | 3803.90 | 94.66 |
| Equity | 1080.50 | 1079.60 | 0.08 | 1080.50 | 1079.60 | 0.08 | 1079.70 | 1078.50 | 0.11 |
| PBIDTM(%) | 29.54 | 24.35 | 21.32 | 29.54 | 24.35 | 21.32 | 24.89 | 20.03 | 24.29 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1941.00 |
| Dr. Reddys Labs. | 1152.60 |
| Cipla | 1410.90 |
| Lupin | 2369.45 |
| Zydus Lifesciences | 1108.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: